Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia.
Kako S, Kanamori H, Kobayashi N, Shigematsu A, Nannya Y, Nakamae M, Shigeno K, Suzukawa K, Takeuchi M, Tsuzuki M, Usuki K, Hatanaka K, Ogawa K, Mitani K, Nawa Y, Hatta Y, Mizuno I, Kanda Y. Kako S, et al. Among authors: shigematsu a. Br J Haematol. 2013 Apr;161(1):95-103. doi: 10.1111/bjh.12225. Epub 2013 Feb 1. Br J Haematol. 2013. PMID: 23368421 Free article.
Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A, Kondo T, Yamamoto S, Sugita J, Onozawa M, Kahata K, Endo T, Shiratori S, Ota S, Obara M, Wakasa K, Takahata M, Takeda Y, Tanaka J, Hashino S, Nishio M, Koike T, Asaka M, Imamura M. Shigematsu A, et al. Biol Blood Marrow Transplant. 2008 May;14(5):568-75. doi: 10.1016/j.bbmt.2008.02.018. Biol Blood Marrow Transplant. 2008. PMID: 18410899 Free article.
Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia.
Shigematsu A, Tanaka J, Suzuki R, Atsuta Y, Kawase T, Ito YM, Yamashita T, Fukuda T, Kumano K, Iwato K, Yoshiba F, Kanamori H, Kobayashi N, Fukuhara T, Morishima Y, Imamura M. Shigematsu A, et al. Int J Hematol. 2011 Nov;94(5):463-71. doi: 10.1007/s12185-011-0944-2. Epub 2011 Nov 1. Int J Hematol. 2011. PMID: 22042561 Free article.
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Kanamori H, Mizuta S, Kako S, Kato H, Nishiwaki S, Imai K, Shigematsu A, Nakamae H, Tanaka M, Ikegame K, Yujiri T, Fukuda T, Minagawa K, Eto T, Nagamura-Inoue T, Morishima Y, Suzuki R, Sakamaki H, Tanaka J. Kanamori H, et al. Among authors: shigematsu a. Bone Marrow Transplant. 2013 Nov;48(12):1513-8. doi: 10.1038/bmt.2013.140. Epub 2013 Sep 23. Bone Marrow Transplant. 2013. PMID: 24056740
High level of serum soluble interleukin-2 receptor at transplantation predicts poor outcome of allogeneic stem cell transplantation for adult T cell leukemia.
Shigematsu A, Kobayashi N, Yasui H, Shindo M, Kakinoki Y, Koda K, Iyama S, Kuroda H, Tsutsumi Y, Imamura M, Teshima T. Shigematsu A, et al. Biol Blood Marrow Transplant. 2014 Jun;20(6):801-5. doi: 10.1016/j.bbmt.2014.02.014. Epub 2014 Feb 22. Biol Blood Marrow Transplant. 2014. PMID: 24565990 Free article.
Ultra-high level of serum soluble interleukin-2 receptor at diagnosis predicts poor outcome for angioimmunoblastic T-cell lymphoma.
Shiratori S, Kosugi-Kanaya M, Shigematsu A, Kobayashi H, Yamamoto S, Kobayashi N, Iwasaki H, Mori A, Kunieda Y, Yutaka T, Kurosawa M, Kakinoki Y, Endo T, Kondo T, Hashino S, Teshima T; North Japan Hematology Study Group (NJHSG). Shiratori S, et al. Among authors: shigematsu a. Leuk Lymphoma. 2015;56(9):2592-7. doi: 10.3109/10428194.2014.1001985. Epub 2015 Feb 24. Leuk Lymphoma. 2015. PMID: 25563559
A Safety and Efficacy Study of Medium-Dose Etoposide, Cyclophosphamide and Total Body Irradiation Conditioning Before Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia.
Shigematsu A, Ozawa Y, Onizuka M, Fujisawa S, Suzuki R, Atsuta Y, Hatanaka K, Masuko M, Ito T, Kobayashi N, Kato J, Miyamura K, Fukuda T, Morishima Y, Imamura M. Shigematsu A, et al. Transplant Direct. 2015 Mar 13;1(2):e8. doi: 10.1097/TXD.0000000000000514. eCollection 2015 Mar. Transplant Direct. 2015. PMID: 27500214 Free PMC article.
Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.
Mitsuhashi K, Kako S, Shigematsu A, Atsuta Y, Doki N, Fukuda T, Kanamori H, Onizuka M, Takahashi S, Ozawa Y, Kurokawa M, Inoue Y, Nagamura-Inoue T, Morishima Y, Mizuta S, Tanaka J; Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation. Mitsuhashi K, et al. Among authors: shigematsu a. Biol Blood Marrow Transplant. 2016 Dec;22(12):2194-2200. doi: 10.1016/j.bbmt.2016.09.007. Epub 2016 Sep 13. Biol Blood Marrow Transplant. 2016. PMID: 27638362 Free article.
High-dose cytarabine added to CY/TBI improves the prognosis of cord blood transplantation for acute lymphoblastic leukemia in adults: a retrospective cohort study.
Arai Y, Kondo T, Shigematsu A, Tanaka J, Takahashi S, Kobayashi T, Uchida N, Onishi Y, Ishikawa J, Kanamori H, Sawa M, Yokota A, Kouzai Y, Takanashi M, Ichinohe T, Atsuta Y, Mizuta S. Arai Y, et al. Among authors: shigematsu a. Bone Marrow Transplant. 2016 Dec;51(12):1636-1639. doi: 10.1038/bmt.2016.242. Epub 2016 Sep 19. Bone Marrow Transplant. 2016. PMID: 27643870 No abstract available.
Allogeneic stem cell transplantation for adult patients with acute lymphoblastic leukemia who had central nervous system involvement: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Shigematsu A, Kako S, Mitsuhashi K, Iwato K, Uchida N, Kanda Y, Fukuda T, Sawa M, Senoo Y, Ogawa H, Miyamura K, Takada S, Nagamura-Inoue T, Morishima Y, Ichinohe T, Atsuta Y, Mizuta S, Tanaka J. Shigematsu A, et al. Int J Hematol. 2017 Jun;105(6):805-811. doi: 10.1007/s12185-017-2197-1. Epub 2017 Feb 14. Int J Hematol. 2017. PMID: 28197965 Clinical Trial.
307 results